Market Dynamics:
Market Research Future (MRFR) says that the global Dental Biomaterials Market could achieve a CAGR of 6.2% during the forecast period (2018-2023).
Growth Boosters and Top Challenges:
The World Health Organization (WHO) says that oral diseases as one of the most expensive diseases prevalent, not only in developing countries but also in the developed ones. The OECD 2013 analysis concludes that the treatment of oral diseases such as dental biomaterials accounted for 5% of the total health expenditure in economically stable countries. Dental biomaterials are advanced products within preventive and restorative dentistry that have a high success rate in oral treatment as well as prevention. This favorable aspect of these products is bound to create demand for the global dental biomaterials market in the subsequent years.
The quickly increasing number of qualified dental professionals could elevate access to dental care. Recent statistics released by the Brazilian Institute of Geography and Statistics (IBGE) states that the country has about 174,000 dentists, which translates to 11% of the total number in the world. Following the implementation of the Oral Health National Policy in Brazil since 2004, there has been a rise in population that is more aware of oral health.
Prominent Companies
- Dentsply Sirona
- Geistlich Pharma AG
- Zimmer Biomet Holdings
- 3M Company
- Straumann Holding AG
- Carpenter Technology Corporation
- Kuraray Co
- Medtronic PLC
- Henry Schein
- GC Corporation
- Royal DSM
Market Segmentation:
- The global dental biomaterials market has been segmented on the basis of type, application, and end-user.
- Type-based segments covered by the report are ceramic biomaterials, metallic biomaterials, metal-ceramic biomaterials, polymeric biomaterials, and natural biomaterials. The metallic biomaterials segment has been split into stainless steel, chromium alloys and titanium, and others.
- Applications of dental biomaterials are prosthodontics, implantology, orthodontics, and others.
- The end-user segment consists of dental laboratories, dental product manufacturers, dental academies, research institutes, and dental hospitals and clinics.
Regional Outlook
Asia Pacific, Middle East & Africa, the Americas and Europe are the main markets for dental biomaterials.
The Americas controls the major portion of the global dental biomaterials market. The growing prevalence of caries, combined with the presence of renowned players in the region leaves a positive impact on the market. On top of that, high dental expenditure boosts the regional market. An article by the American College of Prosthodontists divulged that roughly over 36 million Americans are missing teeth and around 120 million are missing at least one tooth. These conditions in the region help raising the demand for prosthodontics and implants, which elevates the market position.
Europe is the second-most profitable market for dental biomaterials market. Europe market is divided into Eastern Europe and Western Europe. Western Europe, with a bigger share of the market, benefits from the presence of highly developed countries and a rising number of dental procedures. Other than this, massive government funding in the field helps with market growth. In 2018, Oral Health Foundation had reported that nearly 60% of adults in Northern Ireland and 61% of adults in England visited NHS dentists on a regular basis. These numbers clearly indicate the positive market scope for the future.
